ANIK
Anika Therapeutics Inc
Price:  
25.14 
USD
Volume:  
58,291.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Anika Relative Valuation

-240.6%
Upside

As of 2024-03-03, the Relative Valuation of Anika Therapeutics Inc (ANIK) is (35.34) USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.14 USD, the upside of Anika Therapeutics Inc based on Relative Valuation is -240.6%.

The range of the Relative Valuation is (28.88) - (36.16) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 17.2x - 26.3x 22.4x
Forward P/E multiples 16.7x - 21.5x 19.7x
Fair Price (28.88) - (36.16) (35.34)
Upside -214.9% - -243.9% -240.6%
25.14 USD
Stock Price
(35.34) USD
Fair Price

Anika Relative Valuation - Historical P/E Data

Date P/E
2024-03-01 -14.97
2024-02-29 -14.46
2024-02-28 -14.75
2024-02-27 -15.05
2024-02-26 -15.13
2024-02-23 -15.42
2024-02-22 -14.79
2024-02-21 -14.66
2024-02-20 -14.44
2024-02-16 -14.42
2024-02-15 -14.65
2024-02-14 -14.05
2024-02-13 -13.88
2024-02-12 -14.30
2024-02-09 -14.31
2024-02-08 -14.09
2024-02-07 -13.94
2024-02-06 -14.26
2024-02-05 -13.95
2024-02-02 -13.76
2024-02-01 -13.94
2024-01-31 -14.01
2024-01-30 -14.60
2024-01-29 -14.94
2024-01-26 -14.53
2024-01-25 -14.40
2024-01-24 -13.81
2024-01-23 -13.64
2024-01-22 -13.36
2024-01-19 -13.25
2024-01-18 -13.37
2024-01-17 -13.37
2024-01-16 -13.07
2024-01-12 -13.33
2024-01-11 -13.64
2024-01-10 -13.79
2024-01-09 -13.37
2024-01-08 -13.47
2024-01-05 -13.15
2024-01-04 -13.22
2024-01-03 -13.48
2024-01-02 -13.50
2023-12-29 -13.50
2023-12-28 -13.48
2023-12-27 -13.51
2023-12-26 -13.58
2023-12-22 -13.88
2023-12-21 -13.49
2023-12-20 -13.26
2023-12-19 -13.38